Process View
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of transcription from rna polymerase ii promoter in response to hypoxia"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 1.000 | ||
| NRP1 | neuropilin 1 | 1.000 | ||
| JAG1 | jagged 1 | 0.999 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.998 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.993 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.988 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.988 | ||
| SP1 | Sp1 transcription factor | 0.986 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.981 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.979 | Human | |
| VHL | von Hippel-Lindau tumor suppressor | 0.977 | ||
| EP300 | E1A binding protein p300 | 0.977 | ||
| SMAD3 | SMAD family member 3 | 0.977 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.961 | ||
| NOTCH3 | notch 3 | 0.925 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.890 | ||
| PGF | placental growth factor | 0.872 | Human | |
| MAML1 | mastermind-like 1 (Drosophila) | 0.809 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.580 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.570 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.511 | ||
| CREBBP | CREB binding protein | 0.487 | ||
| LDLR | low density lipoprotein receptor | 0.453 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.425 | Human | |
| XIAP | X-linked inhibitor of apoptosis | 0.353 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.327 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.309 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.304 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.283 | ||
| RUNX1 | runt-related transcription factor 1 | 0.257 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.247 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.242 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.237 | ||
| HTT | huntingtin | 0.233 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.230 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.208 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.197 | ||
| ESR1 | estrogen receptor 1 | 0.183 | ||
| STC1 | stanniocalcin 1 | 0.149 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.149 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.131 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.119 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.118 | ||
| AHR | aryl hydrocarbon receptor | 0.107 | ||
| FOXO3 | forkhead box O3 | 0.106 | ||
| PKM2 | pyruvate kinase, muscle | 0.098 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.091 | ||
| JAG2 | jagged 2 | 0.086 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.085 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.084 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.083 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.082 | Human | |
| NCOA2 | nuclear receptor coactivator 2 | 0.078 | ||
| NOTCH2 | notch 2 | 0.073 | ||
| AR | androgen receptor | 0.069 | ||
| MEF2C | myocyte enhancer factor 2C | 0.068 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.064 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.064 | ||
| CXXC5 | CXXC finger protein 5 | 0.063 | ||
| POU2F1 | POU class 2 homeobox 1 | 0.061 | ||
| HDAC1 | histone deacetylase 1 | 0.058 | ||
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.058 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.057 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.055 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.053 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.050 | ||
| JUN | jun proto-oncogene | 0.045 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.044 | ||
| TP53 | tumor protein p53 | 0.044 | ||
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.041 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.040 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.038 | ||
| PDGFC | platelet derived growth factor C | 0.036 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.036 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.036 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.035 | ||
| FOXO1 | forkhead box O1 | 0.032 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.032 | ||
| MTA1 | metastasis associated 1 | 0.031 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.030 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.027 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.027 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.027 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.026 | ||
| FOSL2 | FOS-like antigen 2 | 0.026 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.025 | ||
| STC2 | stanniocalcin 2 | 0.025 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.023 | ||
| ATXN1L | ataxin 1-like | 0.023 | ||
| EGR1 | early growth response 1 | 0.023 | ||
| MED15 | mediator complex subunit 15 | 0.021 | ||
| DEDD | death effector domain containing | 0.020 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.019 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.019 | ||
| G0S2 | G0/G1switch 2 | 0.018 | ||
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.018 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.017 | ||
| ADM | adrenomedullin | 0.017 | ||
| ATF3 | activating transcription factor 3 | 0.017 | ||
| CNOT4 | CCR4-NOT transcription complex, subunit 4 | 0.016 | ||
| YY1 | YY1 transcription factor | 0.016 | ||
| CUX1 | cut-like homeobox 1 | 0.016 | ||
| EGLN2 | egl nine homolog 2 (C. elegans) | 0.016 | ||
| IER2 | immediate early response 2 | 0.016 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.015 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.015 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.015 | ||
| EFNB2 | ephrin-B2 | 0.014 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.014 | ||
| PRDM4 | PR domain containing 4 | 0.014 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.014 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.014 | ||
| MDFI | MyoD family inhibitor | 0.014 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.014 | ||
| GLI1 | GLI family zinc finger 1 | 0.014 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.013 | ||
| IER3 | immediate early response 3 | 0.013 | ||
| SRCAP | Snf2-related CREBBP activator protein | 0.013 | ||
| KLF13 | Kruppel-like factor 13 | 0.013 | ||
| FKBP5 | FK506 binding protein 5 | 0.013 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.012 | ||
| ZNF358 | zinc finger protein 358 | 0.012 | ||
| EFNA1 | ephrin-A1 | 0.012 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.012 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.012 | ||
| VLDLR | very low density lipoprotein receptor | 0.012 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.011 | ||
| KDM2A | lysine (K)-specific demethylase 2A | 0.010 | ||
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.010 | ||
| HOXB7 | homeobox B7 | 0.010 | ||
| C7orf68 | chromosome 7 open reading frame 68 | 0.010 |